Monthly Antibody MAR001 Cut Triglycerides 39% to 46% Beyond Placebo Without Worsening Blood Sugar in 235-Person Trial

In a randomized Phase 2b trial, experimental antibody MAR001 significantly lowered triglycerides and remnant cholesterol, but its ability to prevent heart attacks, strokes or pancreatitis remains unknown.